Another meta-analysis in symptomatic patients showed that FIT using 10 μg Hb/g feces as the cutoff level had a sensitivity of 92.1% for CRC alone; however, when including advanced adenoma, sensitivity dropped to 62.6%5. Here, GSTM1 is linked to colorectal carcinoma.